NaseeruddinAhmedKhanMDFASN

Kidney & Pancreas Transplantation

Nephrology

Dr. Khan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Naseeruddin Khan, based in Dallas, TX, specializes in nephrology with a subspecialty focus on kidney and pancreas transplantation. He completed his residency in Internal Medicine and fellowship in Nephrology at the Washington University/B-JH/SLCH Consortium. With experience in general nephrology, transplant nephrology, dialysis, peritoneal dialysis, and obesity-related disorders, he has also authored publications such as "Hydralazine-Induced Isolated Lupus Nephritis" and "Canagliflozin-induced Fanconi syndrome." In 2013, he received the CMS Meaningful Use Stage 1 Certification from EpicCare Ambulatory EMR.

Washington University/B-JH/SLCH ConsortiumFellowship, Nephrology, 1997 - 1999
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1994 - 1997
King Edward Medical UniversityClass of 1991

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

PubMed

2 citations
Hydralazine-Induced Isolated Lupus Nephritis.
Naseer Khan, Ronald R. Reichel, Ayesha Khurshid, Katie Tso, Joan Broussard
Ochsner Journal. 2020-01-01
2 citations
Canagliflozin-induced Fanconi syndrome in a patient with previously unrecognized type 1 diabetes.
Naseer Khan, Katie Tso, Joan Broussard, Monica Dziuba
American Journal of Health-System Pharmacy. 2019-11-13